Barclays’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3
| Closed | – | – | 4438 |
|
|
2024
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4394 |
|
|
2022
Q3 | – | Sell |
-8,430
| Closed | -$28K | – | 4768 |
|
|
2022
Q2 | $28K | Buy |
+8,430
| New | +$28K | ﹤0.01% | 3965 |
|
|
2021
Q4 | – | Sell |
-631
| Closed | -$9K | – | 3632 |
|
|
2021
Q3 | $9K | Sell |
631
-1,752
| -74% | -$25K | ﹤0.01% | 3765 |
|
|
2021
Q2 | $44K | Sell |
2,383
-1,333
| -36% | -$24.6K | ﹤0.01% | 3443 |
|
|
2021
Q1 | $86K | Buy |
3,716
+1,273
| +52% | +$29.5K | ﹤0.01% | 3417 |
|
|
2020
Q4 | $45K | Sell |
2,443
-527
| -18% | -$9.71K | ﹤0.01% | 3214 |
|
|
2020
Q3 | $76K | Sell |
2,970
-286
| -9% | -$7.32K | ﹤0.01% | 3124 |
|
|
2020
Q2 | $94K | Sell |
3,256
-4,287
| -57% | -$124K | ﹤0.01% | 3146 |
|
|
2020
Q1 | $363K | Sell |
7,543
-5,299
| -41% | -$255K | ﹤0.01% | 2270 |
|
|
2019
Q4 | $730K | Buy |
12,842
+10,929
| +571% | +$621K | ﹤0.01% | 2480 |
|
|
2019
Q3 | $119K | Sell |
1,913
-474
| -20% | -$29.5K | ﹤0.01% | 3314 |
|
|
2019
Q2 | $107K | Buy |
2,387
+1,075
| +82% | +$48.2K | ﹤0.01% | 3556 |
|
|
2019
Q1 | $83K | Buy |
1,312
+892
| +212% | +$56.4K | ﹤0.01% | 3420 |
|
|
2018
Q4 | $22K | Sell |
420
-1,036
| -71% | -$54.3K | ﹤0.01% | 3359 |
|
|
2018
Q3 | $146K | Buy |
1,456
+1,167
| +404% | +$117K | ﹤0.01% | 3220 |
|
|
2018
Q2 | $20K | Sell |
289
-491
| -63% | -$34K | ﹤0.01% | 3648 |
|
|
2018
Q1 | $39K | Buy |
780
+39
| +5% | +$1.95K | ﹤0.01% | 3616 |
|
|
2017
Q4 | $35K | Buy |
741
+656
| +772% | +$31K | ﹤0.01% | 3493 |
|
|
2017
Q3 | $5K | Sell |
85
-117
| -58% | -$6.88K | ﹤0.01% | 3653 |
|
|
2017
Q2 | $15K | Buy |
202
+41
| +25% | +$3.05K | ﹤0.01% | 3347 |
|
|
2017
Q1 | $11K | Sell |
161
-485
| -75% | -$33.1K | ﹤0.01% | 3515 |
|
|
2016
Q4 | $61K | Buy |
+646
| New | +$61K | ﹤0.01% | 2764 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4013 |
|